Sat, January 9, 2010
Fri, January 8, 2010
Thu, January 7, 2010
Wed, January 6, 2010
Tue, January 5, 2010
Mon, January 4, 2010
[ Mon, Jan 04th 2010 ]: Market Wire
Cordani Becomes CIGNA CEO
Thu, December 31, 2009
[ Thu, Dec 31st 2009 ]: Market Wire
Quit the Board
Wed, December 30, 2009
Tue, December 29, 2009
Mon, December 28, 2009
Thu, December 24, 2009
Wed, December 23, 2009
Tue, December 22, 2009
Mon, December 21, 2009
Fri, December 18, 2009
Thu, December 17, 2009
Wed, December 16, 2009
Tue, December 15, 2009
Mon, December 14, 2009
Fri, December 11, 2009
Thu, December 10, 2009
Wed, December 9, 2009
Tue, December 8, 2009
Mon, December 7, 2009

Retractable Technologies, Inc. Announces Verdict in Patent Infringement Suit Against OMI

  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. ict-in-patent-infringement-suit-against-omi.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

LITTLE ELM, Texas--([ BUSINESS WIRE ])--Retractable Technologies, Inc. ("Retractable") (AMEX: RVP), a leading maker of safety needle devices, announced today that a Tyler, Texas jury returned a verdict on Friday, December 18th in the litigation of Retractable Technologies, Inc. v. OMI (Occupational & Medical Innovations Limited, an Australian public company,) in favor of Retractable on all claims presented to the jury. The jury found that OMI's Auto-Retractable Safety Syringe infringed all the asserted claims under patent 6,572,584 ("the ‘584 patent"), OMI was directed to pay Retractable $1,571,103 for such infringement and found that Retractable's ‘584 patent is valid and enforceable. In addition, the jury found that OMI misappropriated trade secret information and was directed to pay Retractable $2,240,640 in damages.

Retractable will seek the entry of an immediate injunction against any further infringement. Issuance of an injunction is a matter for the Court but the Company is informed by counsel that all relevant legal factors weigh in favor of injunctive relief in this case.

Retractable manufactures and markets safety medical products, principally VanishPoint® automated retraction safety syringes and blood collection devices, that virtually eliminate healthcare worker exposure to accidental needlestick injuries. These revolutionary devices use a patented friction ring mechanism that causes the contaminated needle to retract automatically, a feature that is designed to prevent both accidental needlestick injury and device reuse. Retractable also manufactures and markets Patient Safe™ syringes that are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. Retractable's products are distributed by various specialty and general line distributors. For more information on Retractable, visit our website at [ www.vanishpoint.com ].

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect our current views with respect to future events. We believe that the expectations reflected in such forward-looking statements are accurate. However, we cannot assure you that such expectations will materialize. Our actual future performance could differ materially from such statements.

Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain liquidity; our maintenance of patent protection; the impact of current litigation (as it affects our costs as well as market access); the ability to maintain favorable supplier arrangements and relationships; the ability to receive royalties from Baiyin Tonsun Medical Device Co., Ltd.; our ability to quickly increase capacity in response to a dramatic increase in demand (such as by increased orders due to swine flu vaccinations); our ability to access the market; our ability to maintain or lower production costs; our ability to continue to finance research and development as well as operations and expansion of production; the increased interest of larger market players, specifically Becton Dickinson and Company, in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.